ReviewBMC infectious diseases2025

Early combined therapy for COVID-19 in immunocompromised patients: a promising approach against viral persistence and drug resistance.

Salvatore Rotundo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.